Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Return on Assets (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Return on Assets data on record, last reported at 1.84% in Q3 2025.

  • For Q3 2025, Return on Assets fell 28.0% year-over-year to 1.84%; the TTM value through Sep 2025 reached 1.84%, down 28.0%, while the annual FY2024 figure was 1.42%, 13.0% down from the prior year.
  • Return on Assets reached 1.84% in Q3 2025 per BTAI's latest filing, up from 2.03% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.73% in Q4 2022 and bottomed at 2.06% in Q4 2023.
  • Average Return on Assets over 4 years is 1.61%, with a median of 1.73% recorded in 2023.
  • Peak YoY movement for Return on Assets: plummeted -132bps in 2023, then rose 26bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.73% in 2022, then tumbled by -180bps to 2.06% in 2023, then rose by 12bps to 1.82% in 2024, then decreased by -1bps to 1.84% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 1.84% in Q3 2025, 2.03% in Q2 2025, and 1.71% in Q1 2025.